How Data and AI Can Optimise Pharmaceutical Supply Chains

ABSTRACT

Pharmaceutical supply chains are highly complex, global, and tightly regulated systems that are increasingly exposed to disruption from geopolitical instability, pandemics, and demand volatility. This report examines how data and Artificial Intelligence (AI) can optimise pharmaceutical supply chains by improving forecasting accuracy, manufacturing efficiency, inventory management, logistics, quality assurance, and regulatory compliance. It argues that the industry is transitioning from isolated AI pilots toward integrated, intelligent, and potentially autonomous supply chain systems underpinned by data-driven decision-making, digital twins, and agentic AI. The report highlights the foundational role of data, emphasising that its value depends on contextualisation, integration, and governance across fragmented systems. AI applications such as machine learning-based demand forecasting, predictive inventory optimisation, and real-time analytics enable more responsive and efficient supply chain operations. In manufacturing, digital twins and predictive maintenance systems improve yield, reduce downtime, and enhance quality consistency, while AI-enabled logistics and warehouse optimisation strengthen cold-chain integrity and distribution efficiency. The report also explores AI applications in quality management and regulatory compliance, including anomaly detection, computer vision inspection, and automated documentation aligned with Good Manufacturing Practice (GMP) standards. Major technology providers such as IBM, SAP, Siemens, Microsoft, and GE Digital are enabling these capabilities through advanced industrial AI platforms. Finally, the report considers the emerging potential of agentic AI to enable autonomous decision-making across end-to-end supply chains, while recognising persistent challenges related to data quality, regulatory constraints, cybersecurity risks, and organisational readiness. Overall, the findings suggest that AI has the potential to transform pharmaceutical supply chains into more resilient, adaptive, and patient-centric systems, provided that technological innovation is matched with robust governance and organisational change.

KEYWORDS

• Agentic AI
• Artificial Intelligence
• Digital twins
• Pharmaceutical Supply Chains
• Predictive Analytics

Showing references and in-text citations exactly as published.

• DOI10.5530/bems.12.2.9Copy

RELATED ARTICLES

Matched on section and article type within this issue of BEMSR.

• Article · VOLUME 12, ISSUE 2Toxicological Assessment and Risk Management of Pharmaceutical ImpuritiesArun HS Kumar* · pp. 33–46Brief ReportSame type: Article
• Article · VOLUME 12, ISSUE 2Beyond Outbreak Counts: A Novel Epidemiological Classification of Major Animal Diseases Using Loss-to-Case and Cases-per-Outbreak RatiosArun HS Kumar* · pp. 53–57Brief ReportSame type: Article
• Article · VOLUME 12, ISSUE 2The Koebner Phenomenon and First Episode of Psoriasis after Contact with Cold Metal in Fitzpatrick Type II SkinPriya Kadam, Irrum Aneela · pp. 30–32Same type: Article
• Article · VOLUME 12, ISSUE 2Comparative Analysis of Vascular Density in the Femoral Head Ligament of the Dog, Sheep, and GoatImani Stanard, Hazem Almhanna, Aqeel Mohsin Mahdi Al-Mahmodi, David Kilroy­, Arun HS Kumar­ · pp. 58–64Same type: Article